RBC Capital Downgrades Merck & Co to Sector Perform, Raises Price Target to $150

Benzinga Newsdesk www.benzinga.com Negative 71.8%

Neg 71.8% Neu 0% Pos 0%

RBC Capital analyst Trung Huynh downgrades Merck & Co (NYSE:MRK) from Outperform to Sector Perform and raises the price target from $142 to $150.